Water-soluble contrast medium (Gastrografin) value in adhesive small intestine obstruction (Asio): A prospective, randomized, controlled, clinical trial

被引:77
|
作者
Di Saverio, Salomone [1 ]
Catena, Fausto [1 ]
Ansaloni, Luca [1 ]
Gavioli, Margherita [2 ]
Valentino, Massimo [3 ]
Pinna, Antonio Daniele [1 ]
机构
[1] Univ Bologna, Emergency Surg Unit, Dept Surg, S Orsala Malpighi Univ Hosp, I-40138 Bologna, Italy
[2] Univ Modena, Emergency Surg Dept, Emilia, Italy
[3] S Orsola Malpighi Univ Hosp, Dept Radiol, Bologna, Italy
关键词
D O I
10.1007/s00268-008-9694-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Patients with adhesive small intestine obstruction (ASIO) are difficult to evaluate and to manage and their treatment is still controversial. The diagnostic and therapeutic role of water-soluble contrast medium (Gastrografin) in ASIO is still debated. This study was designed to determine the therapeutic role of Gastrografin in patients with ASIO. Methods The study was a multicenter, prospective, randomized, controlled investigation. The primary end points were the evaluation of the operative rate reduction and shortening the hospital stay after the use of Gastrografin. A total of 76 patients were randomized into two groups: the control group received traditional treatment (TT), whereas the study group (GG) received in addition a Gastrografin meal and follow-through study immediately. Patients with Gastrografin in the colon within 36 hours were considered to be partially obstructed and submitted to nonoperative management. If after 36 hours, the Gastrografin had not entered the colon, the subjects were submitted to laparotomy. Results No significant differences were found in age, sex, intravenous administration of prokinetics, incidence and characteristics of the previous procedures in surgical history of the patients, previous episodes of ASIO and surgery for adhesiolysis, or duration of symptoms before admission. In the GG group obstruction resolved subsequently in 31 of 38 cases (81.5%) after a mean time of 6.4 hours. The remaining seven patients were submitted to surgery, and one of them needed bowel resection for strangulation. In the control group, 21 patients were not submitted to surgery (55%), whereas 17 showed persistent untreatable obstruction and required laparotomy: 2 of them underwent bowel resection for strangulation. The difference in the operative rate between the two treatment groups reached statistical significance (p = 0.013). The time from the hospital admission for obstruction to resolution of symptoms was significantly lower in the GG group (6.4 vs. 43 hours; p < 0.01). The length of hospital stay revealed a significant reduction in the GG group (4.7 vs. 7.8 days; p < 0.05). This reduction was more evident in the subset of patients who did not require surgery (3 vs. 5.1 days; p < 0.01). No GG-related complications or significant differences in major complications and the relapse rate were found (relapse rate, 34.2% after a mean time to relapse of 6.3 months in the GG group vs. 42.1% after 7.6 months in the TT; p = not significant). Conclusions Data showed that the use of Gastrografin in ASIO is safe and reduces the operative rate and the time to resolution of obstruction, as well as the hospital stay.
引用
收藏
页码:2293 / 2304
页数:12
相关论文
共 50 条
  • [41] Water-Soluble Contrast Agent Use in Adhesional Small Bowel Obstruction: A Survey of Surgical Practices and Clinical Trial Considerations
    Aimar, Kelsey
    Walshaw, Josephine
    Peckham-Cooper, Adam
    Smart, Neil
    Magill, Laura
    Lee, Matthew J.
    BJS-BRITISH JOURNAL OF SURGERY, 2025, 112
  • [42] Contrast radiography in small bowel obstruction: A prospective, randomized trial
    Anderson, CA
    Humphrey, WT
    MILITARY MEDICINE, 1997, 162 (11) : 749 - 752
  • [43] Water-soluble contrast study predicts the need for early surgery in adhesive small bowel obstruction - Letter 2
    Guthrie, HC
    Cadogan, M
    Murchison, JT
    Paterson-Brown, S
    BRITISH JOURNAL OF SURGERY, 1999, 86 (05) : 714 - 715
  • [44] Evaluating suspected small bowel obstruction with the water-soluble contrast challenge
    Lawrence, Edward M.
    Pickhardt, Perry J.
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1130):
  • [45] Water-Soluble Contrast Agents in Small Bowel Obstruction: A Useful Discriminator
    Stallmann, Hein P.
    Borstlap, Jaap
    Bollen, Thomas L.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (06) : W783 - W783
  • [46] A WATER-SOLUBLE CONTRAST MEDIUM FOR BRONCHOGRAPHY - REPORT ON CLINICAL USE
    ATWELL, RJ
    PEDERSEN, RL
    DISEASES OF THE CHEST, 1950, 18 (06): : 535 - 541
  • [47] Evaluation of a water-soluble contrast protocol for small bowel obstruction: A southwestern surgical congress multicenter trial
    Moskowitz, Eliza E.
    McIntyre, Robert C.
    Burlew, Clay Cothren
    Helmkamp, Laura J.
    Peltz, Erik D.
    Coleman, Julia R.
    Kovar, Alexandra
    Truitt, Michael
    Agrawal, Vaidehi
    Onkendi, Edwin
    Dev, Rushabh
    Diaz, Jose J.
    Eaton, Barbara
    Campion, Eric M.
    AMERICAN JOURNAL OF SURGERY, 2019, 218 (06): : 1046 - 1051
  • [48] The Effect of Hyperosmolar Water-Soluble Contrast for the Management of Adhesive Small Bowel Obstruction A Systematic Review and Meta-Analysis
    Klingbeil, Kyle D. D.
    Wu, James X. X.
    Osuna-Garcia, Antonia
    Livingston, Edward H. H.
    ANNALS OF SURGERY, 2022, 276 (06) : 981 - 988
  • [49] Therapeutic effect of gastrografin and predictors of operative intervention in patients with adhesive small bowel obstruction: A randomized controlled study
    Khorshidi, Hamid Reza
    Majidi, Parviz
    Pirdehghan, Azar
    TURKISH JOURNAL OF SURGERY, 2019, 35 (02) : 131 - 135
  • [50] Randomized controlled trial of a water-soluble formulation of lutein in humans
    Kobayashi, Junya
    Tominaga, Etsuko
    Ozeki, Makoto
    Okubo, Tsutomu
    Nakagawa, Kiyotaka
    Miyazawa, Teruo
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2019, 83 (12) : 2372 - 2374